Paroxetine HCl-loaded hybrid nanoparticles for intranasal application to brain delivery: evaluation and cell culture studies
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Advanced Drug Delivery Systems · Nanoparticle-Based Drug Delivery · Lipid Membrane Structure and Behavior
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Vitorino C, Silva S, Gouveia F, Bicker J, Falcão A, Fortuna A (2020) QbD-driven development of intranasal lipid nanoparticles for depression treatment. Eur J Pharm Biopharm 153:106–12010.1016/j.ejpb.2020.04.011 ↗
2. Alberto M, Paiva-Santos AC, Veiga F, Pires PC (2022) Lipid and polymeric nanoparticles: successful strategies for nose-to-brain drug delivery in the treatment of depression and anxiety disorders. Pharmaceutics 14(12):274210.3390/pharmaceutics14122742 ↗
3. Esim O, Savaser A, Ozkan CK, Oztuna A, Goksel BA, Ozler M, Tas C, Ozkan Y (2020) Nose to brain delivery of eletriptan hydrobromide nanoparticles: preparation, in vitro/in vivo evaluation and effect on trigeminal activation. J Drug Deliv Sci Technol. https://doi.org/10.1016/j.jddst.2020.10191910.1016/j.jddst.2020.101919 ↗
4. Awad R, Avital A, Sosnik A (2022) Polymeric nanocarriers for nose-to-brain drug delivery in neurodegenerative diseases and neurodevelopmental disorders. Acta Pharm Sin B. 13(5):1866–1886. https://doi.org/10.1016/j.apsb.2022.07.00310.1016/j.apsb.2022.07.003 ↗
5. Giunchedi P, Gavini E, Bonferoni MC (2020) Nose-to-brain delivery. Pharmaceutics 12(2):13810.3390/pharmaceutics12020138 ↗
6. Sipos B, Csóka I, Budai-Szűcs M, Kozma G, Berkesi D, Kónya Z, Balogh GT, Katona G (2021) Development of dexamethasone-loaded mixed polymeric micelles for nasal delivery. Eur J Pharm Sci 166:10596010.1016/j.ejps.2021.105960 ↗
7. Trevino J, Quispe R, Khan F, Novak V (2020) Non-invasive strategies for nose-to-brain drug delivery. J Clin Trials 10(7):439
8. Karavasili C, Fatouros DG (2016) Smart materials: in situ gel-forming systems for nasal delivery. Drug Discov Today 21(1):157–16610.1016/j.drudis.2015.10.016 ↗
9. Wavikar PR, Vavia PR (2015) Rivastigmine-loaded in situ gelling nanostructured lipid carriers for nose to brain delivery. J Liposome Res 25(2):141–14910.3109/08982104.2014.954129 ↗
10. Alshweiat A, Ambrus R, Csóka I (2019) Intranasal nanoparticulate systems as alternative route of drug delivery. Curr Med Chem 26(35):6459–649210.2174/0929867326666190827151741 ↗
11. Thakkar H, Vaghela D, Patel BP (2021) Brain targeted intranasal in-situ gelling spray of paroxetine: formulation, characterization and in-vivo evaluation. J Drug Deliv Sci Technol 62:10231710.1016/j.jddst.2020.102317 ↗
12. Esim O, Hascicek C, Gedik ME, Gunaydin G, Dogan AL (2022) Carboplatin and decitabine loaded lipid-coated albumin nanoparticles for an efficient treatment of platinum-resistant ovarian cancer. J Drug Deliv Sci Technol. https://doi.org/10.1016/j.jddst.2022.10380110.1016/j.jddst.2022.103801 ↗
13. Esim O, Kiymaci ME, Hascicek C (2023) Ciprofloxacin HCl-loaded albumin nanoparticles for the treatment of recurrent urinary tract infections: preparation, optimization, and evaluation of antibacterial activity. J Pharm Innov. https://doi.org/10.1007/s12247-023-09709-610.1007/s12247-023-09709-6 ↗
14. Sengel-Turk CT, Hascicek C, Dogan AL, Esendagli G, Guc D, Gonul N (2014) Surface modification and evaluation of PLGA nanoparticles: the effects on cellular uptake and cell proliferation on the HT-29 cell line. J Drug Deliv Sci Technol 24(2):166–17210.1016/S1773-2247(14)50027-5 ↗
15. Bonaccorso A, Gigliobianco MR, Lombardo R, Pellitteri R, Martino PD, Mancuso A, Musumeci T (2023) Nanonized carbamazepine for nose-to-brain delivery: pharmaceutical formulation development. Pharm Dev Technol 28(2):248–26310.1080/10837450.2023.2177673 ↗
16. Jia L, Nie X-q, Ji H-m, Yuan Z-x, Li R-s (2021) Multiple-Coated PLGA nanoparticles loading triptolide attenuate injury of a cellular model of Alzheimer’s disease. BioMed Res Int 25:8825640. https://doi.org/10.1155/2021/882564010.1155/2021/8825640 ↗
17. Artursson P, Lindmark T, Davis SS, Illum L (1994) Effect of chitosan on the permeability of monolayers of intestinal epithelial cells (Caco-2). Pharm Res 11(9):1358–136110.1023/A:1018967116988 ↗
18. Costa CP, Barreiro S, Moreira JN, Silva R, Almeida H, Sousa Lobo JM, Silva AC (2021) In vitro studies on nasal formulations of nanostructured lipid carriers (NLC) and solid lipid nanoparticles (SLN). Pharmaceuticals 14(8):71110.3390/ph14080711 ↗
19. Cros CD, Toth I, Blanchfield JT (2011) Lipophilic derivatives of leu-enkephalinamide: in vitro permeability, stability and in vivo nasal delivery. Bioorg Med Chem 19(4):1528–153410.1016/j.bmc.2010.12.042 ↗
20. Hafner A, Lovric J, Voinovich D, Filipovic-Grcic J (2009) Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers. Int J Pharm 381(2):205–21310.1016/j.ijpharm.2009.07.001 ↗
21. Ghasemi M, Turnbull T, Sebastian S, Kempson I (2021) The MTT assay: utility, limitations, pitfalls, and interpretation in bulk and single-cell analysis. Int J Mol Sci 22(23):1282710.3390/ijms222312827 ↗
22. Esim O, Sarper M, Ozkan CK, Oren S, Baykal B, Savaser A, Ozkan Y (2020) Effect simultaneous delivery with P-glycoprotein inhibitor and nanoparticle administration of doxorubicin on cellular uptake and in vitro anticancer activity. Saudi Pharm J 28(4):465–47210.1016/j.jsps.2020.02.008 ↗
23. Ahmaditabar P, Momtazi-Borojeni AA, Rezayan AH, Mahmoodi M, Sahebkar A, Mellat M (2017) Enhanced entrapment and improved in vitro controlled release of N-acetyl cysteine in hybrid PLGA/lecithin nanoparticles prepared using a nanoprecipitation/self-assembly method. J Cell Biochem 118(12):4203–420910.1002/jcb.26070 ↗
24. Chronopoulou L, Massimi M, Giardi MF, Cametti C, Devirgiliis LC, Dentini M, Palocci C (2013) Chitosan-coated PLGA nanoparticles: a sustained drug release strategy for cell cultures. Colloids Surf, B 103:310–31710.1016/j.colsurfb.2012.10.063 ↗
25. Pitchika S, Sahoo SK (2022) Paclitaxel and lapatinib dual loaded chitosan-coated PLGA nanoparticles enhance cytotoxicity by circumventing MDR1-mediated trastuzumab resistance in HER2 positive breast cancers: in-vitro and in-vivo studies. J Drug Deliv Sci Technol. https://doi.org/10.1016/j.jddst.2022.10344510.1016/j.jddst.2022.103445 ↗
26. Suri R, Neupane YR, Mehra N, Nematullah M, Khan F, Alam O, Iqubal A, Jain GK, Kohli K (2021) Sirolimus loaded chitosan functionalized poly (lactic-co-glycolic acid)(PLGA) nanoparticles for potential treatment of age-related macular degeneration. Int J Biol Macromol 191:548–55910.1016/j.ijbiomac.2021.09.069 ↗
27. Liang J, Liu Y, Liu J, Li Z, Fan Q, Jiang Z, Yan F, Wang Z, Huang P, Feng N (2018) Chitosan-functionalized lipid-polymer hybrid nanoparticles for oral delivery of silymarin and enhanced lipid-lowering effect in NAFLD. J Nanobiotechnol 16(1):1–1210.1186/s12951-018-0391-9 ↗
28. Shinde U, Barkat Y, Singh K (2023) Coloaded surface–modified PLGA nanoparticles for sustained ocular delivery of levofloxacin and flurbiprofen. J Pharm Innov 18(4):2348–236110.1007/s12247-023-09796-5 ↗
29. Aldawsari HM, Alhakamy NA, Padder R, Husain M, Md S (2020) Preparation and characterization of chitosan coated PLGA nanoparticles of resveratrol: improved stability, antioxidant and apoptotic activities in H1299 lung cancer cells. Coatings. https://doi.org/10.3390/coatings1005043910.3390/coatings10050439 ↗
30. Alshememry A, Kalam MA, Almoghrabi A, Alzahrani A, Shahid M, Khan AA, Haque A, Ali R, Alkholief M, Binkhathlan Z (2022) Chitosan-coated poly (lactic-co-glycolide) nanoparticles for dual delivery of doxorubicin and naringin against MCF-7 cells. J Drug Deliv Sci Technol 68:10303610.1016/j.jddst.2021.103036 ↗
31. Lima IAd, Khalil NM, Tominaga TT, Lechanteur A, Sarmento B, Mainardes RM (2018) Mucoadhesive chitosan-coated PLGA nanoparticles for oral delivery of ferulic acid. Artif Cells Nanomed Biotechnol 46(sup2):993–100210.1080/21691401.2018.1477788 ↗
32. Alshetaili AS (2021) Gefitinib loaded PLGA and chitosan coated PLGA nanoparticles with magnified cytotoxicity against A549 lung cancer cell lines. Saudi J Biol Sci 28(9):5065–507310.1016/j.sjbs.2021.05.025 ↗
33. Irfan Z, Khan MI, Sohail MF, Akhtar MF, Qaisar MN, Javed MK, Anwar F, Anwar M, Khan A, Akram F (2024) Development and characterization of glimepiride-loaded polymeric nanoparticles: formulation design and evaluation. J Pharm Innov 19(1):510.1007/s12247-024-09812-2 ↗
34. Patil M (2021) Mucoadhesion as a strategy to enhance the direct nose-to-brain drug delivery. In: Pardeshi CV (ed) Direct nose-to-brain drug delivery. Elsevier, Souto EB, pp 115–15610.1016/B978-0-12-822522-6.00007-2 ↗
35. Jeong S-H, Jang J-H, Lee Y-B (2022) Drug delivery to the brain via the nasal route of administration: exploration of key targets and major consideration factors. J Pharm Investig (1). https://doi.org/10.1007/s40005-022-00589-510.1007/s40005-022-00589-5 ↗
36. Meng Q, Wang A, Hua H, Jiang Y, Wang Y, Mu H, Wu Z, Sun K (2018) Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer’s disease. Int J Nanomed 13:70510.2147/IJN.S151474 ↗
37. Bi C, Wang A, Chu Y, Liu S, Mu H, Liu W, Wu Z, Sun K, Li Y (2016) Intranasal delivery of rotigotine to the brain with lactoferrin-modified PEG-PLGA nanoparticles for Parkinson’s disease treatment. Int J Nanomed 11:654710.2147/IJN.S120939 ↗
38. Liu S, Han X, Liu H, Zhao Y, Li H, Rupenthal I, Lv Z, Chen Y, Yang F, Ping Q (2020) Incorporation of ion exchange functionalized-montmorillonite into solid lipid nanoparticles with low irritation enhances drug bioavailability for glaucoma treatment. Drug Delivery 27(1):652–6110.1080/10717544.2020.1756984 ↗
39. Jafari S, Maleki-Dizaji N, Barar J, Barzegar-Jalali M, Rameshrad M, Adibkia K (2016) Methylprednisolone acetate-loaded hydroxyapatite nanoparticles as a potential drug delivery system for treatment of rheumatoid arthritis: in vitro and in vivo evaluations. Eur J Pharm Sci 91:225–23510.1016/j.ejps.2016.05.014 ↗
40. Lopes-de-Araújo J, Neves AR, Gouveia VM, Moura CC, Nunes C, Reis S (2016) Oxaprozin-loaded lipid nanoparticles towards overcoming NSAIDs side-effects. Pharm Res 33:301–31410.1007/s11095-015-1788-x ↗
41. Bose RJ, Lee SH, Park H (2016) Lipid-based surface engineering of PLGA nanoparticles for drug and gene delivery applications. Biomater Res 20:3410.1186/s40824-016-0081-3 ↗
42. Esim O, Oztuna A, Sarper M, Hascicek C (2022) Chitosan-coated bovine serum albumin nanocarriers mediate efficient delivery of methotrexate in breast cancer therapeutics. J Drug Deliv Sci Technol. https://doi.org/10.1016/j.jddst.2022.10390610.1016/j.jddst.2022.103906 ↗
43. Ahmad N (2017) Rasagiline-encapsulated chitosan-coated PLGA nanoparticles targeted to the brain in the treatment of Parkinson’s disease. J Liq Chromatogr Relat Technol 40(13):677–69010.1080/10826076.2017.1343735 ↗
44. Bruinsmann FA, Pigana S, Aguirre T, Dadalt Souto G, Garrastazu Pereira G, Bianchera A, Tiozzo Fasiolo L, Colombo G, Marques M, Raffin Pohlmann A (2019) Chitosan-coated nanoparticles: effect of chitosan molecular weight on nasal transmucosal delivery. Pharmaceutics 11(2):8610.3390/pharmaceutics11020086 ↗
45. Yu S-H, Tang D-W, Hsieh H-Y, Wu W-S, Lin B-X, Chuang E-Y, Sung H-W, Mi F-L (2013) Nanoparticle-induced tight-junction opening for the transport of an anti-angiogenic sulfated polysaccharide across Caco-2 cell monolayers. Acta Biomater 9(7):7449–745910.1016/j.actbio.2013.04.009 ↗
46. Chin LY, Tan JYP, Choudhury H, Pandey M, Sisinthy SP, Gorain B (2021) Development and optimization of chitosan coated nanoemulgel of telmisartan for intranasal delivery: a comparative study. J Drug Deliv Sci Technol 62:10234110.1016/j.jddst.2021.102341 ↗